{"disease":{"id":"thyroid-cancer-anaplastic","name":"thyroid cancer anaplastic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03565536","title":"Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT07485569","title":"Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04552769","title":"Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT04644315","title":"A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}